AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
Erythromycin Estolate Equivalent To
19 registrations across 1 African market— 11 active
Markets with Erythromycin Estolate Equivalent To
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| ADCO-ERYTHROMYCIN 125 mg/5 ml | 🇿🇦South Africa | Adcock Ingram Limited | suspended | Dec 2024 |
| A-LENNON ERYTHROMYCIN ES 250 mg/5 ml | 🇿🇦South Africa | Pharmacare Limited û Woodmead | suspended | Jul 2024 |
| A-LENNON ERYTHROMYCIN ES - 250 mg CAPSULES | 🇿🇦South Africa | Pharmacare Limited û Woodmead | suspended | Jul 2024 |
| ILOSONE 500 | 🇿🇦South Africa | Pharmacare Limited û Woodmead | suspended | Jul 2024 |
| LILLY-ERYTHROMYCIN 250P | 🇿🇦South Africa | Pharmacare Limited û Woodmead | suspended | Jul 2024 |
| LILLY-ERYTHROMYCIN 125P | 🇿🇦South Africa | Pharmacare Limited û Woodmead | suspended | Jul 2024 |
| ILOSONE 250 | 🇿🇦South Africa | Pharmacare Limited û Woodmead | suspended | Jul 2024 |
| ERYMIN S* | 🇿🇦South Africa | WARNER-LAMBERT SA (PTY) LTD | suspended | Jun 2022 |
| BETAMYCIN GRANULES 125 mg* | 🇿🇦South Africa | Ranbaxy Pharmaceutical (Pty) Ltd | active | May 1997 |
| ILOSONE 125 P | 🇿🇦South Africa | QUATROMED LIMITED | active | Jan 1900 |
| SPECTRASONE SF 250 | 🇿🇦South Africa | Alliance Pharma (Pty) Ltd | active | Jan 1900 |
| RYPED | 🇿🇦South Africa | THE PREMIER PHARMACEUTICAL CO LTD | active | Jan 1900 |
| SPECTRASONE S 125 | 🇿🇦South Africa | Alliance Pharma (Pty) Ltd | active | Jan 1900 |
| PURMYCIN - 500 | 🇿🇦South Africa | Adcock Ingram Limited | active | Jan 1900 |
| PURMYCIN - 125 SUSPENSION | 🇿🇦South Africa | Adcock Ingram Limited | active | Jan 1900 |
| SPECTRASONE C 250 | 🇿🇦South Africa | Arya Pharma (Pty) Ltd | active | Jan 1900 |
| PURMYCIN - 250 SUSPENSION | 🇿🇦South Africa | Adcock Ingram Limited | active | Jan 1900 |
| ERYTHROMYCIN 125mg/5ml PHARMC | 🇿🇦South Africa | Pharmacorp (Pty) Ltd | active | Jan 1900 |
| PURMYCIN CAPSULES | 🇿🇦South Africa | Adcock Ingram Limited | active | Jan 1900 |
Erythromycin Estolate Equivalent To in Africa — Regulatory Overview
Erythromycin Estolate Equivalent To is registered across 1 African markets with 19 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa. AfricaRegulatory refreshes this data daily from official government sources.
Of the 19 registrations, 11 (58%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.